Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV
Jan 9, 2015
PDF 18.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases
Jan 7, 2015
PDF 13.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Jan 6, 2015
PDF 11.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds
Nov 25, 2014
PDF 13.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference
Nov 24, 2014
PDF 10.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference
Nov 13, 2014
PDF 10.5 KB Add to Briefcase
View Summary Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases
Nov 6, 2014
PDF 18.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference
Nov 5, 2014
PDF 10.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results
Nov 3, 2014
PDF 23.9 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation
Nov 3, 2014
PDF 20.6 KB Add to Briefcase
View Summary Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting
Oct 31, 2014
PDF 22.7 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl
Oct 28, 2014
PDF 19.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3
Oct 27, 2014
PDF 12.1 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at the American College of Clinical Pharmacy Annual Meeting
Oct 13, 2014
PDF 18.3 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine
Oct 10, 2014
PDF 51.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Sep 22, 2014
PDF 10.4 KB Add to Briefcase
View Summary Lorcaserin HCl Data to be Presented at the American Society of Bariatric Physicians' 64th Annual Obesity & Associated Conditions Symposium
Sep 10, 2014
PDF 19.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension
Sep 2, 2014
PDF 11.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results
Aug 1, 2014
PDF 24.6 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
Jul 30, 2014
PDF 17.4 KB Add to Briefcase
Showing 21-40 of 493 Page: 1 2 3 4 5 6 ... 25  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase